{"id":"https://openalex.org/W2283176086","doi":"https://doi.org/10.1158/0008-5472.can-15-2820","title":"Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer","display_name":"Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer","alternate_titles":[],"publication_year":2016,"publication_date":"2016-03-31","ids":{"openalex":"https://openalex.org/W2283176086","doi":"https://doi.org/10.1158/0008-5472.can-15-2820","mag":"2283176086","pmid":"https://pubmed.ncbi.nlm.nih.gov/26880801"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-15-2820","doi":"https://doi.org/10.1158/0008-5472.can-15-2820","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-15-2820","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2283176086"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101461393","display_name":"Chinthalapally V. Rao","orcid":"https://orcid.org/0000-0002-5715-7979","observed_orcids":["https://orcid.org/0000-0002-5715-7979"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Chinthalapally V. Rao","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102801230","display_name":"Naveena B. Janakiram","orcid":"https://orcid.org/0000-0002-0138-4654","observed_orcids":["https://orcid.org/0000-0002-0138-4654"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Naveena B. Janakiram","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039291412","display_name":"Venkateshwar Madka","orcid":"https://orcid.org/0000-0002-8896-4095","observed_orcids":["https://orcid.org/0000-0002-8896-4095"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Venkateshwar Madka","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091411272","display_name":"Gaurav Kumar","orcid":"https://orcid.org/0000-0001-5464-6518","observed_orcids":["https://orcid.org/0000-0001-5464-6518"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gaurav Kumar","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052632230","display_name":"Edgar J. Scott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Edgar J. Scott","raw_affiliation_strings":["2Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082289517","display_name":"Gopal Pathuri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gopal Pathuri","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043424904","display_name":"Taylor Bryant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Taylor Bryant","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090739602","display_name":"Hannah Kutche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hannah Kutche","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100451831","display_name":"Yuting Zhang","orcid":"https://orcid.org/0000-0002-5467-2510","observed_orcids":["https://orcid.org/0000-0002-5467-2510"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuting Zhang","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061363547","display_name":"Laura Biddick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Biddick","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058818623","display_name":"Hariprasad Gali","orcid":"https://orcid.org/0000-0003-0846-6334","observed_orcids":["https://orcid.org/0000-0003-0846-6334"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hariprasad Gali","raw_affiliation_strings":["3College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091113010","display_name":"Yan Daniel Zhao","orcid":"https://orcid.org/0000-0003-3448-0527","observed_orcids":["https://orcid.org/0000-0003-3448-0527"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yan D. Zhao","raw_affiliation_strings":["4Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059170204","display_name":"Stan A. Lightfoot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stan Lightfoot","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043464019","display_name":"Altaf Mohammed","orcid":"https://orcid.org/0000-0003-1058-6909","observed_orcids":["https://orcid.org/0000-0003-1058-6909"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Altaf Mohammed","raw_affiliation_strings":["1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma","institution_ids":["https://openalex.org/I49332381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043464019","https://openalex.org/A5101461393"],"corresponding_institution_ids":["https://openalex.org/I49332381"],"apc_list":null,"apc_paid":null,"fwci":1.4348,"has_fulltext":false,"cited_by_count":63,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.80349383,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"76","issue":"7","first_page":"1965","last_page":"1974"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.7035999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.7035999894142151,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.28859999775886536,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gcnt3","display_name":"GCNT3","score":0.9750000238418579},{"id":"https://openalex.org/keywords/mucin-production","display_name":"mucin production","score":0.9580000042915344},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9909999966621399},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/kras-driven-tumors","display_name":"KRAS-driven tumors","score":0.75},{"id":"https://openalex.org/keywords/drug-delivery-barriers","display_name":"drug delivery barriers","score":0.5149999856948853},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.597000002861023},{"id":"https://openalex.org/keywords/patient-survival","display_name":"patient survival","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C179264091","wikidata":"https://www.wikidata.org/wiki/Q410862","display_name":"Mucin","level":2,"score":0.7334846258163452},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7187848687171936},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6555020809173584},{"id":"https://openalex.org/C553450214","wikidata":"https://www.wikidata.org/wiki/Q851162","display_name":"Biosynthesis","level":3,"score":0.5994624495506287},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5295026302337646},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4872978925704956},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3639755845069885},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3515501916408539},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.348856121301651},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.340109646320343},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30979055166244507},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.16106030344963074}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017351","descriptor_name":"N-Acetylglucosaminyltransferases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018396","descriptor_name":"Mucin-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046888","descriptor_name":"Tissue Array Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-15-2820","doi":"https://doi.org/10.1158/0008-5472.can-15-2820","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-15-2820","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:26880801","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26880801","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1470259615","display_name":null,"funder_award_id":"N01-CN-53300","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8270837372","display_name":"Preclinical Efficacy and Intermediate Endpoint Assays","funder_award_id":"n01cn53300-6-0-1","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332607","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1481457736","https://openalex.org/W1586708178","https://openalex.org/W1861261009","https://openalex.org/W1967744862","https://openalex.org/W1975375759","https://openalex.org/W1980123689","https://openalex.org/W2000588306","https://openalex.org/W2007285929","https://openalex.org/W2023571913","https://openalex.org/W2031191632","https://openalex.org/W2046553400","https://openalex.org/W2051615139","https://openalex.org/W2055463789","https://openalex.org/W2066054497","https://openalex.org/W2066135299","https://openalex.org/W2071999665","https://openalex.org/W2072139449","https://openalex.org/W2076211055","https://openalex.org/W2082705267","https://openalex.org/W2101953772","https://openalex.org/W2105007932","https://openalex.org/W2121134199","https://openalex.org/W2138155367","https://openalex.org/W2139733535","https://openalex.org/W2139845107","https://openalex.org/W2143228540","https://openalex.org/W2158294624","https://openalex.org/W2160155178","https://openalex.org/W2160178444","https://openalex.org/W2334689081","https://openalex.org/W2460704635","https://openalex.org/W4297942278"],"related_works":["https://openalex.org/W2741535510","https://openalex.org/W2483462564","https://openalex.org/W2563363007","https://openalex.org/W3216425481","https://openalex.org/W4388942045","https://openalex.org/W2783266766","https://openalex.org/W3011000971","https://openalex.org/W2339917359","https://openalex.org/W3118152225"],"abstract_inverted_index":{"Pancreatic":[0],"cancer":[1,68,85,129],"is":[2],"an":[3],"aggressive":[4,116],"neoplasm":[5],"with":[6,53,95,112,184],"almost":[7],"uniform":[8],"lethality":[9],"and":[10,65,118,122,133,168,181,199,219],"a":[11,148,172],"5-year":[12],"survival":[13,48],"rate":[14],"of":[15,58,98,125,175,195,224],"7%.":[16],"Several":[17],"overexpressed":[18],"mucins":[19,99,196],"that":[20,151,161,206],"impede":[21],"drug":[22,214],"delivery":[23],"to":[24,39,70,101,154,171,191],"pancreatic":[25,54,63,67,84,128,225],"tumors":[26,64],"have":[27,37],"been":[28],"therapeutically":[29],"targeted,":[30],"but":[31],"enzymes":[32],"involved":[33],"in":[34,127,137,182,197,200,221],"mucin":[35,114,208],"biosynthesis":[36,209],"yet":[38],"be":[40],"preclinically":[41],"evaluated":[42],"as":[43,147],"potential":[44],"targets.":[45],"We":[46],"used":[47],"data":[49],"from":[50],"human":[51,66],"patients":[52],"cancer,":[55],"next-generation":[56],"sequencing":[57],"genetically":[59],"engineered":[60],"Kras-driven":[61],"mouse":[62,83],"cells":[69,130],"identify":[71],"the":[72,192],"novel":[73,149],"core":[74],"mucin-synthesizing":[75],"enzyme":[76],"GCNT3":[77,87,107,126,169,188,211],"(core":[78],"2":[79],"\u03b2-1,6":[80],"N-acetylglucosaminyltransferase).":[81],"In":[82,156],"tumors,":[86],"upregulation":[88],"(103-fold;":[89],"P":[90,103],"<":[91,104],"0.0001)":[92],"was":[93,109],"correlated":[94],"increased":[96,113],"expression":[97,108],"(5":[100],"87-fold;":[102],"0.04-0.0003).":[105],"Aberrant":[106],"also":[110],"associated":[111],"production,":[115],"tumorigenesis,":[117],"reduced":[119,131,187],"patient":[120],"survival,":[121],"CRISPR-mediated":[123],"knockout":[124],"proliferation":[132],"spheroid":[134],"formation.":[135],"Using":[136],"silico":[138],"small":[139],"molecular":[140],"docking":[141,158,173],"simulation":[142],"approaches,":[143],"we":[144],"identified":[145],"talniflumate":[146,167,179],"inhibitor":[150],"selectively":[152],"binds":[153],"GCNT3.":[155],"particular,":[157],"predictions":[159],"suggested":[160],"three":[162],"notable":[163],"hydrogen":[164],"bonds":[165],"between":[166],"contribute":[170],"affinity":[174],"-8.3":[176],"kcal/mol.":[177],"Furthermore,":[178],"alone":[180],"combination":[183],"low-dose":[185],"gefitinib":[186],"expression,":[189],"leading":[190],"disrupted":[193],"production":[194],"vivo":[198],"vitro":[201],"Collectively,":[202],"our":[203],"findings":[204],"suggest":[205],"targeting":[207],"through":[210],"may":[212],"improve":[213],"responsiveness,":[215],"warranting":[216],"further":[217],"development":[218],"investigation":[220],"preclinical":[222],"models":[223],"tumorigenesis.":[226],"Cancer":[227],"Res;":[228],"76(7);":[229],"1965-74.":[230],"\u00a92016":[231],"AACR.":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2283176086","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
